Stage III hypertension in patients after mRNA-based SARS-CoV-2 vaccination
S Meylan, F Livio, M Foerster, PJ Genoud… - …, 2021 - Am Heart Assoc
Due to the patient high throughput in our vaccination center, we do not have prevaccination
BP values. However, 8 of 9 patients reported otherwise well controlled hypertension. Our …
BP values. However, 8 of 9 patients reported otherwise well controlled hypertension. Our …
[PDF][PDF] Stage III Hypertension in Patients After mRNA-Based SARS-CoV-2 Vaccination
S Meylan, F Livio, M Foerster, PJ Genoud… - …, 2021 - scholar.archive.org
Due to the patient high throughput in our vaccination center, we do not have prevaccination
BP values. However, 8 of 9 patients reported otherwise well controlled hypertension. Our …
BP values. However, 8 of 9 patients reported otherwise well controlled hypertension. Our …
[HTML][HTML] Stage III Hypertension in Patients After mRNA-Based SARS-CoV-2 Vaccination
S Meylan, F Livio, M Foerster, PJ Genoud… - … (Dallas, Tex.: 1979), 2021 - ncbi.nlm.nih.gov
Due to the patient high throughput in our vaccination center, we do not have prevaccination
BP values. However, 8 of 9 patients reported otherwise well controlled hypertension. Our …
BP values. However, 8 of 9 patients reported otherwise well controlled hypertension. Our …
[引用][C] Stage III Hypertension in Patients After mRNA-Based SARS-CoV-2 Vaccination
S Meylan, F Livio, M Foerster… - … (Dallas, Tex.: 1979 …, 2021 - pubmed.ncbi.nlm.nih.gov
Stage III Hypertension in Patients After mRNA-Based SARS-CoV-2 Vaccination Stage III
Hypertension in Patients After mRNA-Based SARS-CoV-2 Vaccination Hypertension. 2021 …
Hypertension in Patients After mRNA-Based SARS-CoV-2 Vaccination Hypertension. 2021 …
[PDF][PDF] Stage III Hypertension in Patients After mRNA-Based SARS-CoV-2 Vaccination
S Meylan, F Livio, M Foerster, PJ Genoud, F Marguet… - Hypertension, 2021 - serval.unil.ch
Due to the patient high throughput in our vaccination center, we do not have prevaccination
BP values. However, 8 of 9 patients reported otherwise well controlled hypertension. Our …
BP values. However, 8 of 9 patients reported otherwise well controlled hypertension. Our …
Stage III Hypertension in Patients After mRNA-Based SARS-CoV-2 Vaccination.
S Meylan, F Livio, M Foerster, PJ Genoud… - … (Dallas, Tex.: 1979), 2021 - europepmc.org
On January 11, the vaccination center in Lausanne—a city of 140 000 inhabitants in western
Switzerland—started the coronavirus disease 2019 (COVID-19) vaccination with mRNA …
Switzerland—started the coronavirus disease 2019 (COVID-19) vaccination with mRNA …
[引用][C] Stage III Hypertension in Patients After mRNA-Based SARS-CoV-2 Vaccination
S Meylan, F Livio, M Foerster, PJ Genoud, F Marguet… - Hypertension, 2021 - cir.nii.ac.jp
Stage III Hypertension in Patients After mRNA-Based SARS-CoV-2 Vaccination | CiNii
Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 …
Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 …
[PDF][PDF] Stage III Hypertension in Patients After mRNA-Based SARS-CoV-2 Vaccination
S Meylan, F Livio, M Foerster, PJ Genoud, F Marguet… - Hypertension, 2021 - serval.unil.ch
Due to the patient high throughput in our vaccination center, we do not have prevaccination
BP values. However, 8 of 9 patients reported otherwise well controlled hypertension. Our …
BP values. However, 8 of 9 patients reported otherwise well controlled hypertension. Our …
Stage III Hypertension in Patients After mRNA-Based SARS-CoV-2 Vaccination.
S Meylan, F Livio, M Foerster, PJ Genoud… - … (Dallas, Tex.: 1979), 2021 - europepmc.org
Due to the patient high throughput in our vaccination center, we do not have prevaccination
BP values. However, 8 of 9 patients reported otherwise well controlled hypertension. Our …
BP values. However, 8 of 9 patients reported otherwise well controlled hypertension. Our …